Viewing Study NCT07176702

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 4:02 AM

Ignite Modification Date: 2025-12-26 @ 2:55 AM

Study NCT ID: NCT07176702

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-12-05

First Post: 2025-08-26

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy

Sponsor: Shanghai Zhongshan Hospital

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module